Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Exercise plus gene therapy shows promise for treating Lou Gehrig’s disease

15.11.2005


A new study in mice gives hope that a combination of gene therapy and exercise may extend the lives of people who have Lou Gehrig’s disease.



Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, is a chronic and progressive illness that leads to paralysis and ultimately death. There are no known cures, and the only FDA-approved method for treating the disease is a drug that may extend life between three and six months, said Brian Kaspar, the study’s lead author and an assistant professor of pediatrics at Ohio State University.

In the study, some of the mice were treated with a combination of exercise and therapy with a gene known to help protect motor neurons. “The combined therapy nearly doubled the lifespan of mice with ALS,” said Kaspar.


Mice that had ALS but received no treatment lived an average of 120 days. However, mice that were allowed to exercise and also received gene therapy lived an average of 210 days. Healthy mice usually live for one or two years. “Somehow, the two treatments complement each other and benefit the mouse,” said Kaspar, who is also an investigator with the Center for Gene Therapy at Columbus Children’s Research Institute.

He presented the work November 14 in Washington, D.C., at the annual meeting of the Society for Neuroscience.

In the current study, the researchers looked at the effects of exercise both with and without additional gene therapy treatment. A group of mice serving as a control had ALS but received no treatment.

The study also showed that mice with ALS benefited from exercise more if they began earlier in life. Some mice began exercise treatment (with no gene therapy) at 40 days of age, while other mice didn’t start to exercise until 90 days of age.

The mice that started exercising when they were younger lived about a month longer than the control mice, while the mice that began exercising at 90 days of age lived an average of 11 days longer than the control mice.

“The earlier the mice could exercise, the better they did,” Kaspar said.

Studies of other neuronal diseases, such as Parkinson’s and Huntington’s, have suggested that exercise may actually prevent neurons from dying.

In related work, Kaspar and his colleagues found that gene therapy extended mouse survival by about 20 to 25 days. The gene they used, insulin-like growth factor 1 (IGF-1), produces a hormone by the same name. This hormone helps protect motor neurons and also stimulates muscle growth.

“Research suggests that exercise boosts levels of IGF-1 as well as other proteins that may be beneficial,” Kaspar said. “Combining the two had a profound effect on survival and function, suggesting that the treatments together may make a significant difference in ALS progression.”

But while this small study in mice shows promise, researchers still have a ways to go before human trials can begin. Nor can they say what kind of exercise may be best for someone with ALS.

Kaspar and his colleagues have already started the next phase of the mouse study, however – they are training mice to run on a treadmill. Training the animals will let the researchers control how long a mouse can exercise. They hope to be able to measure the effects of different durations of exercise on the disease.

“Understanding how exercise affects gene expression may help us find new therapies that slow down the progression of ALS,” Kaspar said. The disease affects about 30,000 people in the United States, with roughly 5,000 new cases reported each year. Average life expectancy is five years from the onset of the disease.

The cause of ALS is unknown in all but 2 percent of cases, where the disease is caused by a known genetic mutation.

“The ultimate challenge is to figure out what triggers motor neuron death in the other 98 percent of people with the disease,” Kaspar said.

Kaspar conducted the study with Soo Kim, a pre-doctoral fellow in biochemistry at Ohio State; with Liza Grissett and Priya Umapathi, both with Columbus Children’s Research Institute; and with Lindsay Frost, Lindsey Christian and Fred Gage, all with the Salk Institute in La Jolla, Calif.

This work was supported by a grant from Project A.L.S the National Institutes of Health’s National Institute of Neurological Disorders and Stroke.

Brian Kaspar | EurekAlert!
Further information:
http://www.osu.edu

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>